Your browser doesn't support javascript.
loading
Comparison of adult and pediatric pilocytic astrocytomas using competing risk analysis: A population-based study.
Yang, Wuyang; Porras, Jose L; Khalafallah, Adham M; Sun, Yi; Bettegowda, Anya; Mukherjee, Debraj.
Afiliação
  • Yang W; Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Porras JL; Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Khalafallah AM; Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Sun Y; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Bettegowda A; Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Mukherjee D; Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: dmukher1@jhmi.edu.
Clin Neurol Neurosurg ; 212: 107084, 2022 01.
Article em En | MEDLINE | ID: mdl-34875553
ABSTRACT

BACKGROUND:

Pilocytic astrocytoma(PA) is a relatively benign tumor occurring primarily in the pediatric population. Comparison of characteristics and survival of this tumor between adult and pediatric patients in a single, population-based study is yet to be performed.

OBJECTIVE:

We aimed to directly compare the characteristics and survival of pilocytic astrocytoma between pediatric and adult patients in a single, population-based study.

METHODS:

We utilized the SEER database using data from 1983 to 2016. All patients with histologically confirmed, intracranial pilocytic astrocytoma were included and divided into a pediatric(age<18 years) or adult group. Due to lower risk of tumor-specific-mortality, we utilized a competing risk analysis to account for mortality from other causes. Univariable and multivariable competing risk analysis(CRA) was performed, and sub-distribution hazard ratio(SHR) or adjusted SHR(aSHR) was reported.

RESULTS:

A total of 4357 patients comprised the final cohort, with 3014(69.2%) pediatric patients. As compared to the pediatric group, adult patients were predominantly White(p < 0.01), with PA less likely fully resected(p = 0.01), smaller tumor size(p < 0.01), and were less often located in the cerebellum(p < 0.01). Multivariable CRA revealed a worse prognosis for the adult group(p < 0.01), regional or distal extension(p < 0.01), and non-cerebellar locations including frontal(p < 0.01), parietal(p < 0.01), ventricular(p < 0.01) or brainstem(p < 0.01). Improved prognosis was seen with more recent year-of-diagnosis(2003-2016, p = 0.03), gross-total/total resection(p < 0.01), and biopsy only patients(p = 0.02).

CONCLUSIONS:

Pilocytic astrocytomas in adult patients have a worse prognosis than pediatric patients. Cumulative incidence of cancer-specific-mortality is higher in adults when adjusted for other factors. PAs with regional or distal extension and non-cerebellar locations carry worse outcomes. Surgery remains an effective treatment and GTR/TR should be achieved when possible.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Astrocitoma / Neoplasias Encefálicas / Avaliação de Resultados em Cuidados de Saúde / Medição de Risco Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Astrocitoma / Neoplasias Encefálicas / Avaliação de Resultados em Cuidados de Saúde / Medição de Risco Idioma: En Ano de publicação: 2022 Tipo de documento: Article